Results 171 to 180 of about 439,714 (267)

Agreement of ocular biometry and evaluation of IOL calculation using a parameter‑hybrid strategy: a comparison of CASIA2, IOL Master 700, and OA2000 in cataract patients. [PDF]

BMC Ophthalmol
Lin W, Wu S, Chen Y, Chen S, Liu X, Guan Z, Qiu K.   +6 more
europepmc   +1 more source

Programa de Pós-Graduação em Geografia - Dissertações e Teses Defendidas 1997 - Instituto de Geociências - Universidade Federal do Rio de Janeiro [PDF]

Anuário do Instituto de Geociências, 1997
doaj  

Rebuilding the Mucociliary Apparatus in ECRS: TSLP/IL-33 Signaling Synergy and the Residual Molecular Scar of <i>DNASE1L3</i> Following IL-4/13 Blockade. [PDF]

Cells
Fujita R, Ishino T, Oda T, Kawasumi T, Nishida M, Horibe Y, Chikuie N, Taruya T, Hamamoto T, Ueda T, Takeno S.   +10 more
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Programa de Pós-Graduação em Geologia - Teses Defendidas 1996 - Instituto de Geociências - Universidade Federal do Rio de Janeiro [PDF]

Anuário do Instituto de Geociências, 1996
doaj  

A Reactive Synchronized Motion Controller for Dual-Arm Cooperation with Closed-Chain Constraints. [PDF]

Biomimetics (Basel)
Ju F, Wang Z, Ge M, Jin H, Zhao J.
europepmc   +1 more source

Science Masters' Association [PDF]

Nature, 1938
openaire   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

Programa de Pós-Graduação em Geologia - Dissertações e Teses Defendidas 1997 - Instituto de Geociências - Universidade Federal do Rio de Janeiro [PDF]

Anuário do Instituto de Geociências, 1997
doaj